Forte Biosciences Inc. – Underwriting Agreements – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Underwriting Agreements Filter

from 8-K 44 pages 5,709,936 Shares of Common Stock Forte Biosciences, Inc. Underwriting Agreement

from SCHEDULE 13G/A 1 page Joint Filing Statement Pursuant to Rule 13d-1

from 8-K 60 pages 5,630,450 Shares of Common Stock Pre-Funded Warrants to Purchase Up to 619,606 Shares of Common Stock Forte Biosciences, Inc. Underwriting Agreement

from SCHEDULE 13G 1 page Joint Filing Statement Pursuant to Rule 13d-1

from SCHEDULE 13G/A 1 page Joint Acquisition Statement Pursuant to Section 240.13d-1

from SC 13D 1 page Joint Filing Agreement

from 8-K 37 pages 1,403,509 Shares Forte Biosciences, Inc. Common Stock Underwriting Agreement

from 8-K 40 pages Tocagen Inc. 3,000,000 Shares Common Stock ($0.001 Par Value) Underwriting Agreement

from S-1 40 pages Tocagen Inc. (A Delaware Corporation) [●] Shares of Common Stock Underwriting Agreement